Page last updated: 2024-10-24

cell surface receptor signaling pathway via STAT

Definition

Target type: biologicalprocess

An intracellular signal transduction process in which STAT proteins (Signal Transducers and Activators of Transcription) convey a signal to trigger a change in the activity or state of a cell. The STAT cascade begins with receptor activation followed by activation of STAT proteins by kinases. It proceeds through STA dimerization and subsequent nuclear translocation of STAT proteins, and ends with regulation of target gene expression by STAT proteins. [GOC:rjd, PMID:21534947, PMID:24587195]

Cell surface receptor signaling pathway via STAT is a complex process that involves a cascade of molecular events initiated by the binding of a ligand to a cell surface receptor. This pathway is crucial for various cellular functions, including cell growth, differentiation, survival, and immune responses.

Here's a detailed description of the key steps involved:

1. **Ligand Binding and Receptor Dimerization:** The process begins with the binding of a specific ligand to its cognate cell surface receptor. This binding event triggers a conformational change in the receptor, leading to its dimerization. This means that two receptor molecules come together to form a complex.

2. **Activation of Tyrosine Kinases:** Many cell surface receptors involved in STAT signaling are receptor tyrosine kinases (RTKs). Upon ligand binding, the associated tyrosine kinases become activated. These kinases phosphorylate tyrosine residues on the receptor itself and on other signaling proteins, creating docking sites for downstream signaling molecules.

3. **Recruitment of STAT Proteins:** Phosphorylated tyrosine residues on the activated receptor provide docking sites for specific proteins called signal transducers and activators of transcription (STATs). STATs are a family of transcription factors that play a central role in this pathway.

4. **STAT Dimerization and Phosphorylation:** Once recruited to the receptor, STAT proteins become phosphorylated on specific tyrosine residues by the activated tyrosine kinases. This phosphorylation event is essential for STAT activation. Phosphorylated STAT proteins then dimerize, forming a stable dimer complex.

5. **Nuclear Translocation and Gene Transcription:** The STAT dimers, now activated, translocate from the cytoplasm into the nucleus. In the nucleus, they bind to specific DNA sequences called STAT response elements (REs) located in the regulatory regions of target genes. Binding of the STAT dimer to the REs initiates transcription of these genes, leading to the synthesis of new proteins that contribute to the cellular response.

6. **Termination of Signaling:** The STAT signaling pathway is tightly regulated to ensure a precise and timely response. Several mechanisms contribute to the termination of signaling, including:
- Dephosphorylation of STAT proteins by phosphatases, leading to their inactivation.
- Degradation of STAT proteins via proteasomal pathways.
- Negative feedback loops involving other signaling molecules.

7. **Diverse Cellular Responses:** The activation of specific STAT proteins and the downstream genes they regulate lead to a wide range of cellular responses. For instance, STAT1 activation is often associated with immune responses, while STAT3 activation can promote cell growth and survival. The specific cellular outcome depends on the type of ligand, the activated receptor, the STAT proteins involved, and the target genes regulated.

In summary, cell surface receptor signaling pathway via STAT is a complex and highly regulated process that plays a critical role in cellular communication and function. The pathway involves a series of molecular events, from ligand binding to gene transcription, ultimately leading to diverse cellular responses.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Signal transducer and activator of transcription 3A signal transducer and activator of transcription 3 that is encoded in the genome of human. [PRO:WCB, UniProtKB:P40763]Homo sapiens (human)

Compounds (28)

CompoundDefinitionClassesRoles
niclosamideniclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
benzamides;
C-nitro compound;
monochlorobenzenes;
salicylanilides;
secondary carboxamide
anthelminthic drug;
anticoronaviral agent;
antiparasitic agent;
apoptosis inducer;
molluscicide;
piscicide;
STAT3 inhibitor
oleanolic acidhydroxy monocarboxylic acid;
pentacyclic triterpenoid
plant metabolite
nitazoxanidenitazoxanide: a 5-nitrothiazolyl derivative used for a broad range of intestinal parasitic infections including CRYPTOSPORIDIUM and GIARDIA; it is a redox-active nitrothiazolyl-salicylamide prodrugbenzamides;
carboxylic ester
loganinbeta-D-glucoside;
cyclopentapyran;
enoate ester;
iridoid monoterpenoid;
methyl ester;
monosaccharide derivative;
secondary alcohol
anti-inflammatory agent;
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
EC 3.2.1.20 (alpha-glucosidase) inhibitor;
EC 3.4.23.46 (memapsin 2) inhibitor;
neuroprotective agent;
plant metabolite
tetrahydrocurcumintetrahydrocurcumin : A beta-diketone that is curcumin in which both of the double bonds have been reduced to single bonds.beta-diketone;
diarylheptanoid;
polyphenol
metabolite
cryptotanshinonecryptotanshinone: from Salvia miltiorrhizaabietane diterpenoidanticoronaviral agent
ar-turmerone(+)-(S)-ar-turmerone : A sesquiterpenoid that is 2-methylhept-2-en-4-one substituted by a 4-methylphenyl group at position 6. It has been isolated from Peltophorum dasyrachis.

ar-turmerone: potent antivenom against snake bites; isolated form Curcuma longa; structure given in first source
enone;
sesquiterpenoid
EC 3.1.1.7 (acetylcholinesterase) inhibitor;
plant metabolite
swerosideglycoside
nsc 74859NSC 74859: inhibits Stat3 binding activity; structure in first source

S3I-201 : An amidobenzoic acid obtained by formal condensation of the carboxy group of [(4-methylbenzene-1-sulfonyl)oxy]acetic acid with the amino group of 4-amino-2-hydroxybenzoic acid.
amidobenzoic acid;
monohydroxybenzoic acid;
tosylate ester
STAT3 inhibitor
telocinobufagintelocinobufagin: structuresteroid lactone
tizoxanidetizoxanide: major metabolite of nitazoxanide; structure in first sourcesalicylamides
bardoxolone methylmethyl 2-cyano-3,12-dioxooleana-1,9(11)-dien-28-oate: structure in first sourcecyclohexenones
bisabololKamillosan: drug combination containing chamomile and bisabolol; used to treat dermatitissesquiterpenoid
ganoderic acid atriterpenoid
piplartinepiplartine: Antineoplastic Agent, Phytogenic; alkaloid from Piper; structure in first sourcecinnamamides;
dicarboximide
stattic1-benzothiophenes;
C-nitro compound;
sulfone
antineoplastic agent;
radiosensitizing agent;
STAT3 inhibitor
stx-0119STX-0119: antineoplastic; structure in first source
genistein7-hydroxyisoflavonesantineoplastic agent;
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor;
geroprotector;
human urinary metabolite;
phytoestrogen;
plant metabolite;
tyrosine kinase inhibitor
andrographolidecarbobicyclic compound;
gamma-lactone;
labdane diterpenoid;
primary alcohol;
secondary alcohol
anti-HIV agent;
anti-inflammatory drug;
antineoplastic agent;
metabolite
nifuroxazidenifuroxazide: structurebenzoic acids
hylin
2-acetylfuranonaphthoquinone2-acetylfuranonaphthoquinone: has antineoplastic activity; structure in first source
5,15-diphenylporphine5,15-diphenylporphine: structure in first source
wp1066
azd 1480
bp-1-102BP-1-102: a STAT3 inhibitor; structure in first source
phaeosphaeride aphaeosphaeride A: inhibits STAT3-dependent signaling; structure in first source
hydrazinocurcuminhydrazinocurcumin : A pyrazole obtained by cyclocodensation of the two carbonyl groups of curcumin with hydrazine.

hydrazinocurcumin: structure in first source
aromatic ether;
olefinic compound;
polyphenol;
pyrazoles
angiogenesis modulating agent;
antineoplastic agent;
EC 2.3.1.48 (histone acetyltransferase) inhibitor;
EC 2.7.11.1 (non-specific serine/threonine protein kinase) inhibitor